期刊文献+

复方苦参注射液对类风湿性关节炎大鼠血清IL-1β、TNF-α的影响 被引量:18

EFFECTS OF COMPOUND SOPHORA INJECTION ON SERUM IL-1β AND TNF-α IN RATS WITH RHEUMATOID ARTHRITIS
下载PDF
导出
摘要 目的:观察复方苦参注射液对类风湿性关节炎大鼠IL-1β、TNF-α的影响,探讨该药的作用机制。方法:建立Ⅱ型胶原蛋白诱导的大鼠类风湿性关节炎模型(CIA),观察复方苦参注射液对CIA大鼠足肿胀的抑制作用,检测血清IL-1β和TNF-α的水平。结果:复方苦参注射液可以抑制大鼠的足肿胀,并可显著降低IL-1β、TNF-α水平(P<0.05);复方苦参注射液对IL-1β的抑制作用优于正清风痛宁对照组(P<0.05)。结论:复方苦参注射液可以降低炎性因子IL-1β、TNF-α的水平,对RA起到治疗作用。 Objective:To observe the effects of compound sophora injection on serum IL-1β and TNF-α in rats with rheumatoid arthritis,and discuss its mechanism.Methods:Experimental model was induced by type II collagen,the inhibitory effect of injection on rats' paw edema was observed,and serum IL-1β and TNF-α level were determined.Results:Compound sophora injection could inhibit rats' paw edema obviously,and lowered serum IL-1β and TNF-α level of rheumatoid arthritis rats.Conclusion:Compound sophora injection could lower serum IL-1β and TNF-α level which maybe one of the mechanism that compound sophora injection effectively treated rheumatoid arthritis.
作者 姚建
出处 《中国中医药科技》 CAS 2007年第5期324-325,共2页 Chinese Journal of Traditional Medical Science and Technology
基金 黑龙江省中医药管理局基金资助项目
  • 相关文献

参考文献6

二级参考文献35

  • 1路志正,实用中医风湿病学,1996年,246页
  • 2中华人民共和国卫生部,中药新药临床研究指导原则.1,1993年,210页
  • 3王兆铭,中西医结合治疗风湿类疾病,1989年,549页
  • 4Green MJ, Gtough AKS. Serum MMP-3 and MMP- 1 and progression of joint damage in early rheumatoid arthritis [J]. Rheumatology,2003, 42(1): 83-88.
  • 5Tchetverikov I, Ronday HK, et al. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis [J ]. Ann Rheum Dis, 2004,63(7) :881 - 883.
  • 6Garnero P, Geusens P, Landewe R. Biochemical markers of joint tissue turnover in early rheumatoid arthritis [J ]. Clin Exp Rheumatol,2003, 21(5 Suppl 31) :S54 - S58.
  • 7Garnero P, Rousseau J, Delmas PD. Molecular basis and clinical use of biochemical markers of bone, cartilage and synovium in joint diseases[J]. Arthritis Rheum, 2000, 43(5) :953 - 961.
  • 8Gineyts E, Garnero P, Delmas PD. Urinary excretion of glucosylgalactosyl pyridinoline: A specific biochemical marker of synovium degradation[J]. Rheumatology, 2001, 40(3) :315 - 323.
  • 9Garnero P, Gineyts E, Christgau S, et al. Association of baseline levels of urinary glucosyl- galactosyl - pyridinoline and type Ⅱ collagen C- telopeptide with progression of joint destruction in patients with early rheumatoid arthritis[J]. Arthritis Rheum, 2002, 46(1): 21 -30.
  • 10Dayer J M. The saga of the discovery of IL - 1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis [J]. Joint Bone Spine 2002, 69: 123- 132.

共引文献160

同被引文献177

引证文献18

二级引证文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部